Literature DB >> 33893038

Emergency department admissions for myocardial infarction and stroke in France during the first wave of the COVID-19 pandemic: National temporal trends and regional disparities.

Valérie Olié1, Laure Carcaillon-Bentata2, Marie-Michèle Thiam2, Sylvie Haeghebaert2, Céline Caserio-Schönemann2.   

Abstract

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic and the national lockdown have led to significant changes in the use of emergency care by the French population. AIMS: To describe the national and regional temporal trends in emergency department (ED) admissions for myocardial infarction (MI) and stroke, before, during and after the first national lockdown.
METHODS: The weekly numbers of ED admissions for MI and stroke were collected from the OSCOUR® network, which covers 93.3% of all ED admissions in France. National and regional incidence rate ratios from 02 February until 31 May (2020 versus 2017-2019) were estimated using Poisson regression for MI and stroke, before, during and after lockdown.
RESULTS: A decrease in ED admissions was observed for MI (-20% for ST-segment elevation MI and-25% for non-ST-segment elevation MI) and stroke (-18% for ischaemic and-22% for haemorrhagic) during the lockdown. The decrease became significant earlier for stroke than for MI. No compensatory increase in ED admissions was observed at the end of the lockdown for these diseases. Important regional disparities in ED admissions were observed, without correlation with the regional levels of COVID-19 cases. The impact of lockdown on ED admissions was particularly significant in six regions (Ile-de France, Occitanie, Provence-Alpes-Côte d'Azur, Nouvelle Aquitaine, Hauts-de-France and Bretagne).
CONCLUSIONS: The decrease in ED admissions for MI and stroke observed during the lockdown was probably caused by fear of COVID-19 and augmented by the lockdown, and was heterogeneous across the French territory. ED admissions were slow to return to the usual levels from previous years, without a compensatory increase. These results underline the need to reinforce messages directed at the population to encourage them to seek care without delay in case of cardiovascular symptoms.
Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Accident vasculaire cérébral; Acute myocardial infarction; COVID-19; Covid-19; Emergency department; Infarctus du myocarde; Services d’urgence; Stroke; Surveillance syndromique; Syndromic surveillance

Year:  2021        PMID: 33893038     DOI: 10.1016/j.acvd.2021.01.006

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  3 in total

1.  Changes in nationwide in-hospital stroke care during the first four waves of COVID-19 in Germany.

Authors:  Julius Dengler; Konstantin Prass; Frederick Palm; Sven Hohenstein; Vincent Pellisier; Michael Stoffel; Bujung Hong; Andreas Meier-Hellmann; Ralf Kuhlen; Andreas Bollmann; Steffen Rosahl
Journal:  Eur Stroke J       Date:  2022-04-07

2.  Medical and cardio-vascular emergency department visits during the COVID-19 pandemic in 2020: is there a collateral damage? A retrospective routine data analysis.

Authors:  Anna Slagman; Mareen Pigorsch; Felix Greiner; Wilhelm Behringer; Michael Bernhard; Jonas Bienzeisler; Sabine Blaschke; Volker Burst; Katharina Dechant; Michael Dommasch; Sebastian Ewen; André Gries; Felix Patricius Hans; Karl-Georg Kanz; Matthias Klein; Philipp Kümpers; Matthias Napp; Christopher Plata; Alexandra Ramshorn-Zimmer; Joachim Risse; Rainer Röhrig; Rajan Somasundaram; Domagoj Schunk; Felix Walcher; Thomas Walter; Dirk Weismann; Sebastian Wolfrum; Markus Wörnle; Yves Noel Wu; Martin Möckel
Journal:  Clin Res Cardiol       Date:  2022-08-05       Impact factor: 6.138

Review 3.  Effects of healthcare system transformations spurred by the COVID-19 pandemic on management of stroke and STEMI: a registry-based cohort study in France.

Authors:  Emilie Lesaine; Florence Francis-Oliviero; Sandrine Domecq; Marine Bijon; Laura Cetran; Pierre Coste; Quentin Lhuaire; Sahal Miganeh-Hadi; Catherine Pradeau; François Rouanet; Floriane Sevin; Igor Sibon; Florence Saillour-Glenisson
Journal:  BMJ Open       Date:  2022-09-21       Impact factor: 3.006

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.